Opioid crackdown nets scores of doctors and pharmacists

Pharmacy News-1 hour ago

... government healthcare programs, Medicare, Medicaid and Tricare, along with private insurers, for medically unnecessary prescription drugs and compounded .

Doctor among 13 charged in $40 million workers comp fraud involving ...

Chron.com-3 hours ago

The indictment sheds light on the greatly expanding business done by compoundingpharmacies amid a nationwide opioid crisis, in which patients have ...

Arkansas Lawmakers Review New Rule to Regulate Pharmacy ...

www.fox16.com-1 hour ago

"We want to be here," said Lyn Fruchey, the owner of Freiderica Pharmacy and Compounding in downtown Little Rock. "We want to take care of our patients

FDA Warns Against Use of Drug Products Due to Lack of Sterility

American Veterinarian-9 hours ago

The FDA issued a warning letter to Ranier's Compounding in March 2017 after ... sterile practices during an inspection of the company's compounding facility.

Letter to Veterinarians - CYSTORELIN® (gonadorelin)

In June 2018, FDA approved the fourth gonadotropin releasing hormone (GnRH) product, CYSTORELIN® (gonadorelin), for estrous synchrony in lactating dairy cows. The drug is also the second GnRH product approved for estrous synchrony in beef cows. CYSTORELIN (New Animal Drug Application 098-379) is a sterile injectable solution of gonadorelin diacetate tetrahydrate, and when used with cloprostenol sodium as part of a synchronization regimen, the drug can be used to synchronize estrous cycles to allow for fixed time artificial insemination in lactating dairy cows and beef cows. FDA wants to remind you of the benefits of using approved drugs in your practice. Read the letter